Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT:SIPHA)

Market Cap	8.39M -9.5%
Revenue (ttm)	20.23M -35.1%
Net Income	-17.10M
EPS	-9.50
Shares Out	1.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16
Average Volume	35
Open	4.660
Previous Close	4.460
Day's Range	4.660 - 4.660
52-Week Range	3.450 - 6.680
Beta	-0.85
RSI	65.99
Earnings Date	n/a

About BVMT:SIPHA

Société des Industries Pharmaceutiques de Tunisie - S.A. engages in the research, development, manufacture, packaging, and marketing of pharmaceutical products for human use in Tunisia and internationally. It provides rheumatology drugs, such as MYORELAX, NIFLUMIC, and ALGESAL SURACTIVE; stomatology drugs, including HEXABAIN; and ANALGAN CODEINE 300mg/25mg indicated for the symptomatic treatment of moderate and intense pain. The company was founded in 1989 and is headquartered in Ben Arous, Tunisia.

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 744
• Stock Exchange: Tunis Stock Exchange
• Ticker Symbol: SIPHA

Financial Performance

In 2019, BVMT:SIPHA's revenue was 24.40 million, a decrease of -26.47% compared to the previous year's 33.19 million. Losses were -14.52 million, 1.81% more than in 2018.